Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan
- PMID: 25285884
- DOI: 10.1016/j.vaccine.2014.09.054
Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan
Abstract
Background: Pregnant women were prioritized for H1N1 vaccination during the 2009-2010 pandemic. Safety concerns exist with vaccinating pregnant women, particularly in their first trimesters.
Methods: We linked computerized data on H1N1 vaccination, National Health Insurance, and Taiwan Birth Registry and identified events of spontaneous abortions (SABs) and all singleton births that occurred/delivered during November 1, 2009-September 30, 2010. The observation period for each case of SAB (6-19 weeks gestation) was divided into period at risk (1-28 days after vaccination) and control periods (the remaining person-days until SAB). The self-controlled case series method for truncated observational periods assessed the incidence rate ratio (IRR) of SAB during the 1-28 days compared with those in the control period. The case-control design matched each case of adverse fetal outcomes to up to 10 controls on fetal sex and year/month of pregnancy onset, and calculated matched odds ratio (OR) on H1N1 vaccination at <14 or ≥14 weeks gestation.
Results: Sixty-five women with SAB had received H1N1 vaccination at 6-19 weeks gestation. The IRR of SAB for the risk period 1-28 days was 1.03 (95% confidence interval [CI] 0.55-1.93). Among the 147,294 live births and 1354 stillbirths, maternal H1N1 vaccine receipt at <14 weeks gestation was associated with significantly reduced likelihood of small for gestational age (SGA) birth (OR 0.72, 95% CI 0.61-0.84) and birth defect (OR 0.46, 95% CI 0.22-1.00), whereas receipt at ≥14 weeks gestation was associated with significantly reduced likelihood of stillbirth (OR 0.63, 95% CI 0.46-0.86), prematurity (OR 0.90, 95% CI 0.83-0.97), low birth weight (OR 0.81, 95% CI 0.74-0.88), and SGA birth (OR 0.90, 95% CI 0.84-0.97).
Conclusions: H1N1 vaccination during pregnancy did not increase risk of SAB or adverse fetal outcomes.
Keywords: H1N1 virus; MF59 adjuvant; Pregnancy; Taiwan; Vaccine safety.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes.Vaccine. 2013 Dec 2;31(49):5827-33. doi: 10.1016/j.vaccine.2013.09.071. Epub 2013 Oct 10. Vaccine. 2013. PMID: 24120677
-
Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.JAMA. 2012 Jul 11;308(2):165-74. doi: 10.1001/jama.2012.6131. JAMA. 2012. PMID: 22782418
-
Maternal influenza vaccine and risks for preterm or small for gestational age birth.J Pediatr. 2014 May;164(5):1051-1057.e2. doi: 10.1016/j.jpeds.2014.01.037. Epub 2014 Feb 26. J Pediatr. 2014. PMID: 24582484
-
Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.Expert Rev Vaccines. 2012 Aug;11(8):911-21. doi: 10.1586/erv.12.72. Expert Rev Vaccines. 2012. PMID: 23002972 Review.
-
The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review.Hum Vaccin Immunother. 2019;15(3):687-699. doi: 10.1080/21645515.2018.1540807. Epub 2018 Nov 15. Hum Vaccin Immunother. 2019. PMID: 30380986 Free PMC article.
Cited by
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.MMWR Recomm Rep. 2020 Aug 21;69(8):1-24. doi: 10.15585/mmwr.rr6908a1. MMWR Recomm Rep. 2020. PMID: 32820746 Free PMC article.
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.MMWR Recomm Rep. 2024 Aug 29;73(5):1-25. doi: 10.15585/mmwr.rr7305a1. MMWR Recomm Rep. 2024. PMID: 39197095 Free PMC article.
-
Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.Vaccine. 2016 Dec 1;34(49):6057-6068. doi: 10.1016/j.vaccine.2016.03.044. Epub 2016 Jul 16. Vaccine. 2016. PMID: 27431422 Free PMC article. No abstract available.
-
Vaccines in pregnancy: The dual benefit for pregnant women and infants.Hum Vaccin Immunother. 2016 Apr 2;12(4):848-56. doi: 10.1080/21645515.2015.1127485. Hum Vaccin Immunother. 2016. PMID: 26857450 Free PMC article. Review.
-
Pregnancy Incidence in Female Nasopharyngeal Carcinoma Survivors of Reproductive Age: A Population-Based Study.Medicine (Baltimore). 2016 May;95(20):e3729. doi: 10.1097/MD.0000000000003729. Medicine (Baltimore). 2016. PMID: 27196495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical